435 related articles for article (PubMed ID: 17976701)
1. Postoperatively administered vancomycin reaches therapeutic concentration in the cerebral spinal fluid of neurosurgical patients.
Wang Q; Shi Z; Wang J; Shi G; Wang S; Zhou J
Surg Neurol; 2008 Feb; 69(2):126-9; discussion 129. PubMed ID: 17976701
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier penetration of cefepime after neurosurgery.
Wang JF; Wang Q; Zhao LH; Shi GZ; Zhou JX
Chin Med J (Engl); 2007 Jul; 120(13):1176-8. PubMed ID: 17637248
[TBL] [Abstract][Full Text] [Related]
3. The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy.
Chen K; Wu Y; Wang Q; Wang J; Li X; Zhao Z; Zhou J
J Crit Care; 2015 Feb; 30(1):218.e1-5. PubMed ID: 25449880
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin cerebrospinal fluid concentrations after intravenous administration in premature infants.
Reiter PD; Doron MW
J Perinatol; 1996; 16(5):331-5. PubMed ID: 8915929
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections.
Bafeltowska JJ; Buszman E; Mandat KM; Hawranek JK
Surg Neurol; 2004 Aug; 62(2):142-50; discussion 150. PubMed ID: 15261509
[TBL] [Abstract][Full Text] [Related]
6. Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration.
Li X; Sun S; Ling X; Chen K; Wang Q; Zhao Z
Eur J Clin Pharmacol; 2017 Dec; 73(12):1599-1607. PubMed ID: 28849406
[TBL] [Abstract][Full Text] [Related]
7. Factors Influencing Norvancomycin Concentration in Plasma and Cerebrospinal Fluid in Patients After Craniotomy and Dosing Guideline: A Population Approach.
Li X; Wu Y; Sun S; Wang Q; Zhao Z
Clin Ther; 2018 Jan; 40(1):74-82.e1. PubMed ID: 29229228
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic monitoring of cerebrospinal fluid vancomycin concentrations and analysis of their influencing factors in neurosurgical intensive care unit patients].
Yao M; Li J; Shi L; Li Y; Wang L; Guan X; Ouyang B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Oct; 31(10):1252-1257. PubMed ID: 31771724
[TBL] [Abstract][Full Text] [Related]
9. [The efficacy of intraventricularly administered vancomycin in the case of central nervous system infection caused by enterococcus faecalis].
Czaban SL; Lebkowski WJ; Krajewski JP; Borkowski J
Wiad Lek; 2002; 55(9-10):617-25. PubMed ID: 12607418
[TBL] [Abstract][Full Text] [Related]
10. [A case of acute pneumococcal meningitis treated with spinal drainage and vancomycin administration].
Fujita A; Kobayashi A; Tagami M; Takano Y; Matsuyama H; Kawamura M
Masui; 2003 Oct; 52(10):1110-4. PubMed ID: 14598680
[TBL] [Abstract][Full Text] [Related]
11. Clearance of vancomycin during high-efficiency hemodialysis.
Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
[TBL] [Abstract][Full Text] [Related]
12. Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy.
Wang Q; Wu Y; Chen B; Zhou J
BMC Anesthesiol; 2015; 15():33. PubMed ID: 25798070
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients.
Li X; Wu Y; Sun S; Mei S; Wang J; Wang Q; Zhao Z
J Pharm Sci; 2015 Nov; 104(11):3960-3967. PubMed ID: 26239933
[TBL] [Abstract][Full Text] [Related]
14. Drug concentrations in the serum and cerebrospinal fluid of patients treated with norvancomycin after craniotomy.
Wu Y; Kang J; Wang Q
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):305-311. PubMed ID: 27738856
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
Yang RH; Rong XZ; Hua R; Zhang T
Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.
Thomson AH; Staatz CE; Tobin CM; Gall M; Lovering AM
J Antimicrob Chemother; 2009 May; 63(5):1050-7. PubMed ID: 19299472
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic aspects of cerebrospinal fluid penetration of fosfomycin.
Pfeifer G; Frenkel C; Entzian W
Int J Clin Pharmacol Res; 1985; 5(3):171-4. PubMed ID: 4018950
[TBL] [Abstract][Full Text] [Related]
18. An investigation into the vancomycin concentration in the cerebrospinal fluid due to vancomycin intraventricular administration in newborns: a study of 13 cases.
Matsunaga N; Hisata K; Shimizu T
Medicine (Baltimore); 2015 Jun; 94(22):e922. PubMed ID: 26039127
[TBL] [Abstract][Full Text] [Related]
19. Correlation between vancomycin penetration into cerebrospinal fluid and protein concentration in cerebrospinal fluid/serum albumin ratio.
Ishikawa M; Yamazaki S; Suzuki T; Uchida M; Iwadate Y; Ishii I
J Infect Chemother; 2019 Feb; 25(2):124-128. PubMed ID: 30424949
[TBL] [Abstract][Full Text] [Related]
20. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
